Zelira Therapeutics (ASX:ZLD) developing clinically validated medicinal cannabis products

Zelira Therapeutics (ASX:ZLD) developing clinically validated medicinal cannabis products

Zelira Therapeutics Limited (ASX:ZLD) Managing Director Ex USA, Dr Richard Hopkins talks about the company’s pipeline of products in clinical development targeting insomnia, chronic pain and autism, its model for rapid commercialisation, its go-to-market strategy and first revenues from US licensing partners.

You May Also Like

About the Author: Milton Harris

Leave a Reply